Investors Overview

Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (OTCQX: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in...
More

Stock Quote
BONE (Common Stock)
ExchangeOTC BB (US Dollar)
Price$3.40
Change (%) Stock is Down 0.1 (2.86%)
Volume4,127
Data as of 07/01/15 3:56 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
06/24/15Bacterin International Holdings, Inc. Awarded Agreement With Premier, Inc.
BELGRADE, Mont., June 24, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE) has been awarded a new group purchasing agreement for the Bone Tissue Synthetic Implantable Products Category with Premier, Inc. Effective July 1st, 2015, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for its members. Bacterin's contracted product portfolio includes OsteoSponge®, OsteoSelect® DBM Putty, Ost... 
Printer Friendly Version
06/19/15Bacterin International Announces Signing of Agreement With Yankee Alliance
BELGRADE, Mont., June 19, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the signing of an agreement with Yankee Alliance, a group purchasing organization (GPO) with more than 11,500 members. The agreement covers Bacterin's complete line of biologic implants, including 3Demin cortical fiber allografts. The contract is a three-year agreement extending through June 2018. "Yankee Alliance wo... 
Printer Friendly Version
06/03/15Bacterin Announces the Launch of ArthroFuse(TM)
BELGRADE, Mont., June 3, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the release of ArthroFuse, a patent pending allograft specifically designed for the treatment of hammertoe deformities. Hammertoe deformity affects the proximal interphalangeal joint of the lesser metatarsals and often resulting in debilitating joint pain and disability. While 550,000 surgical hammertoe procedures are... 
Printer Friendly Version
05/15/15CORRECTING AND REPLACING -- Bacterin Sets Annual Meeting and Record Dates
BELGRADE, Mont., May 15, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders. Bacterin stockholders of record at the close of business on May 15, 2015 will be entitled to notice of the annual meeting and to vote upon matters considered at the meeting. The annual meeting is scheduled to be held at the Hilton Garden Inn, Denver Tec... 
Printer Friendly Version
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.